Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy
- 1 September 1993
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 27 (2) , 455-464
- https://doi.org/10.1016/0360-3016(93)90259-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathyThe Laryngoscope, 1992
- Improving Diagnostic Accuracy of Cervical Metastases With Computed Tomography and Magnetic Resonance ImagingJAMA Otolaryngology–Head & Neck Surgery, 1990
- Characterization of a whole body imaging technique for PETIEEE Transactions on Nuclear Science, 1990
- Breast microcalcifications after lumpectomy and radiation therapy.Radiology, 1989
- PET in clinical oncologyCancer and Metastasis Reviews, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- Effects of Temporal Sampling, Glucose Metabolic Rates, and Disruptions of the Blood—Brain Barrier on the FDG Model with and without a Vascular Compartment: Studies in Human Brain Tumors with PETJournal of Cerebral Blood Flow & Metabolism, 1986
- False‐positive and false‐negative neck nodesHead & Neck Surgery, 1985
- Labeled 2‐deoxy‐D‐glucose analogs. 18F‐labeled 2‐deoxy‐2‐fluoro‐D‐glucose, 2‐deoxy‐2‐fluoro‐D‐mannose and 14C‐2‐deoxy‐2‐fluoro‐D‐glucoseJournal of Labelled Compounds and Radiopharmaceuticals, 1978